Does Resetting the Immune System Fix Multiple Sclerosis?
Gauruv Bose(University of Ottawa), Mark S. Freedman(University of Ottawa), Harold Atkins(University of Ottawa), Simon Thebault(University of Pennsylvania)
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
September 12, 2019
Cited by 11
Related Papers
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
|Nature Medicine|2000|816
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
|American Journal of Ophthalmology|2006|551
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
|Journal of Computer Assisted Tomography|1980|503
Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [ <sup>18</sup> F]Fluorodeoxyglucose and [ <sup>11</sup> C]Deoxyglucose
|Journal of Cerebral Blood Flow & Metabolism|1985|419